+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Clinical Trial Equipment & Ancillary Solutions Market Size, Share & Trends Analysis Report By Product (Sourcing, Supply/Logistics, Service, Others), By Phase (Phase I, II, III, IV), By Region, And Segment Forecasts, 2024 - 2030

  • PDF Icon

    Report

  • 131 Pages
  • February 2024
  • Region: Global
  • Grand View Research
  • ID: 5450202
Description Jump to:
The global clinical trial equipment & ancillary solutions market size is expected to reach USD 5.10 billion by 2030, expanding at a CAGR of 8.1% from 2024 to 2030. The growing pharmaceutical and medical sectors, globalization of clinical trials, and rising R&D expenditure are the factors driving the market. However, the COVID-19 pandemic has affected the global market, which resulted in slowing down the supply chain of equipment & ancillary supplies. The COVID-19 pandemic has caused major changes in the clinical trial environment. Hundreds of experiments were in progress before the pandemic was halted due to COVID-19 globally. However, the growing demand for new and better treatment options has improved the number of clinical trial in the post-pandemic.

The clinical trial procedure has evolved considerably in recent years. Complex clinical studies are creating new problems throughout the healthcare supply chain. Modern studies frequently involve huge numbers of patients and patient subgroups, as well as numerous nations and research sites. As a result, the number of challenges that supply chain managers confront while working with clinical trial equipment & ancillaries has increased. Renting medical equipment relieves the burden of storage, retrieval, and disposal. Another important decision-making reason is that renting equipment reduces significant upfront expenses and large investments required to furnish licensed clinical trial locations.

The pandemic has created a need for effective therapies and interventions. COVID-19 has changed the way clinical trials are conducted, encouraging the digitization of healthcare and the adoption of cutting-edge technologies and techniques. Such adoptions are likely to propel market growth. Moreover, the high R&D spending by the pharmaceutical company for developing innovative therapies for COVID-19 has further contributed to the market growth.

Clinical Trial Equipment & Ancillary Solutions Market Report Highlights

  • The supply/logistics product segment dominated the market with a revenue share of more than 38.95% in 2023 due to the high number of clinical trials globally, which resulted in increased demand for efficient logistics services
  • The phase III segment dominated the market in 2023 and is expected to maintain its dominance through 2030. Phase III studies are the most effective approach to discovering a new treatment standard
  • North America led the global market in 2022 and is expected to remain dominant even during the forecast years due to a rise in the number of CRO and pharmaceutical & medical companies in the region
  • Asia Pacific is anticipated to witness fastest growth in the clinical trial equipment and ancillary solutions market during the forecast period as it is becoming an increasingly significant site for clinical trial investigations

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Phase
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline.
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. Internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Phase outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Clinical Trial Equipment & Ancillary Solutions Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Evolving Clinical Trials Needs
3.2.1.2. Rising Investment in R&D
3.2.1.3. Growing pharmaceutical & Medical Devices industry
3.2.2. Market restraint analysis
3.2.2.1. Rising Cost of Clinical Trials
3.3. Clinical Trial Equipment & Ancillary Solutions Market Analysis Tools
3.3.1. Industry Analysis - Porter’s Five Forces
3.3.2. PESTEL Analysis
Chapter 4. Clinical Trial Equipment & Ancillary Solutions Market: Product Estimates & Trend Analysis
4.1. Product Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Clinical Trial Equipment & Ancillary Solutions Market, by Product Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following:
4.4.1. Sourcing
4.4.1.1. Sourcing market estimates and forecasts, 2018 - 2030 (USD Million)
4.4.1.2. Procurement
4.4.1.2.1. Procurement market estimates and forecasts, 2018 - 2030 (USD Million)
4.4.1.2.2. Equipment
4.4.1.2.2.1. Equipment market estimates and forecasts, 2018 - 2030 (USD Million)
4.4.1.2.3. Ancillaries
4.4.1.2.3.1. Ancillaries market estimates and forecasts, 2018 - 2030 (USD Million)
4.4.1.3. Rental
4.4.1.3.1. Rental market estimates and forecasts, 2018 - 2030 (USD Million)
4.4.1.3.1.1. Equipment market estimates and forecasts, 2018 - 2030 (USD Million)
4.4.1.3.2. Ancillaries
4.4.1.3.2.1. Ancillaries market estimates and forecasts, 2018 - 2030 (USD Million)
4.4.2. Supply/ Logistics
4.4.2.1. Supply/logistics market estimates and forecasts, 2018 - 2030 (USD Million)
4.4.2.2. Transportation
4.4.2.2.1. Transportation market estimates and forecasts, 2018 - 2030 (USD Million)
4.4.2.3. Packaging
4.4.2.3.1. Packaging market estimates and forecasts, 2018 - 2030 (USD Million)
4.4.2.4. Others
4.4.2.4.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
4.4.3. Service
4.4.3.1. Service market estimates and forecasts, 2018 - 2030 (USD Million)
4.4.3.2. Calibrations
4.4.3.2.1. Calibrations market estimates and forecasts, 2018 - 2030 (USD Million)
4.4.3.3. Equipment Servicing
4.4.3.3.1. Equipment servicing market estimates and forecasts, 2018 - 2030 (USD Million)
4.4.3.4. Others
4.4.3.4.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
4.4.4. Others
4.4.4.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 5. Clinical Trial Equipment & Ancillary Solutions Market: Phase Estimates & Trend Analysis
5.1. Phase Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Clinical Trial Equipment & Ancillary Solutions Market, by Phase Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following:
5.4.1. Phase I
5.4.1.1. Phase I market estimates and forecasts, 2018 - 2030 (USD Million)
5.4.2. Phase II
5.4.2.1. Phase II market estimates and forecasts, 2018 - 2030 (USD Million)
5.4.3. Phase III
5.4.3.1. Phase III market estimates and forecasts, 2018 - 2030 (USD Million)
5.4.4. Phase IV
5.4.4.1. Phase IV market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 6. Clinical Trial Equipment & Ancillary Solutions Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2023 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Market Size & Forecasts and Trend Analysis, 2018 to 2030:
6.5. North America
6.5.1. U.S.
6.5.1.1. Key country dynamics
6.5.1.2. Regulatory framework
6.5.1.3. Competitive scenario
6.5.1.4. U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.2. Canada
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework
6.5.2.3. Competitive scenario
6.5.2.4. Canada market estimates and forecasts, 2018 - 2030 (USD Million)
6.6. Europe
6.6.1. UK
6.6.1.1. Key country dynamics
6.6.1.2. Regulatory framework
6.6.1.3. Competitive scenario
6.6.1.4. UK market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.2. Germany
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework
6.6.2.3. Competitive scenario
6.6.2.4. Germany market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.3. France
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework
6.6.3.3. Competitive scenario
6.6.3.4. France market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.4. Italy
6.6.4.1. Key country dynamics
6.6.4.2. Regulatory framework
6.6.4.3. Competitive scenario
6.6.4.4. Italy market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.5. Spain
6.6.5.1. Key country dynamics
6.6.5.2. Regulatory framework
6.6.5.3. Competitive scenario
6.6.5.4. Spain market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.6. Norway
6.6.6.1. Key country dynamics
6.6.6.2. Regulatory framework
6.6.6.3. Competitive scenario
6.6.6.4. Norway market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.7. Sweden
6.6.7.1. Key country dynamics
6.6.7.2. Regulatory framework
6.6.7.3. Competitive scenario
6.6.7.4. Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
6.6.8. Denmark
6.6.8.1. Key country dynamics
6.6.8.2. Regulatory framework
6.6.8.3. Competitive scenario
6.6.8.4. Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
6.7. Asia Pacific
6.7.1. Japan
6.7.1.1. Key country dynamics
6.7.1.2. Regulatory framework
6.7.1.3. Competitive scenario
6.7.1.4. Japan market estimates and forecasts, 2018 - 2030 (USD Million)
6.7.2. China
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework
6.7.2.3. Competitive scenario
6.7.2.4. China market estimates and forecasts, 2018 - 2030 (USD Million)
6.7.3. India
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework
6.7.3.3. Competitive scenario
6.7.3.4. India market estimates and forecasts, 2018 - 2030 (USD Million)
6.7.4. Australia
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework
6.7.4.3. Competitive scenario
6.7.4.4. Australia market estimates and forecasts, 2018 - 2030 (USD Million)
6.7.5. South Korea
6.7.5.1. Key country dynamics
6.7.5.2. Regulatory framework
6.7.5.3. Competitive scenario
6.7.5.4. South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
6.7.6. Thailand
6.7.6.1. Key country dynamics
6.7.6.2. Regulatory framework
6.7.6.3. Competitive scenario
6.7.6.4. Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
6.8. Latin America
6.8.1. Brazil
6.8.1.1. Key country dynamics
6.8.1.2. Regulatory framework
6.8.1.3. Competitive scenario
6.8.1.4. Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
6.8.2. Mexico
6.8.2.1. Key country dynamics
6.8.2.2. Regulatory framework
6.8.2.3. Competitive scenario
6.8.2.4. Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
6.8.3. Argentina
6.8.3.1. Key country dynamics
6.8.3.2. Regulatory framework
6.8.3.3. Competitive scenario
6.8.3.4. Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
6.8.4. Colombia
6.8.4.1. Key country dynamics
6.8.4.2. Regulatory framework
6.8.4.3. Competitive scenario
6.8.4.4. Colombia market estimates and forecasts, 2018 - 2030 (USD Million)
6.9. MEA
6.9.1. South Africa
6.9.1.1. Key country dynamics
6.9.1.2. Regulatory framework
6.9.1.3. Competitive scenario
6.9.1.4. South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
6.9.2. Saudi Arabia
6.9.2.1. Key country dynamics
6.9.2.2. Regulatory framework
6.9.2.3. Competitive scenario
6.9.2.4. Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
6.9.3. UAE
6.9.3.1. Key country dynamics
6.9.3.2. Regulatory framework
6.9.3.3. Competitive scenario
6.9.3.4. UAE market estimates and forecasts, 2018 - 2030 (USD Million)
6.9.4. Kuwait
6.9.4.1. Key country dynamics
6.9.4.2. Regulatory framework
6.9.4.3. Competitive scenario
6.9.4.4. Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2023
7.3.4. Ancillare, LP
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Imperial CRS, Inc.
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Woodley Equipment Company Ltd.
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Thermo Fisher Scientific, Inc.
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Parexel International (MA) Corporation
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Emsere (MediCapital Rent)
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Quipment SAS
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives
7.3.11. IRM
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Product benchmarking
7.3.11.4. Strategic initiatives
7.3.12. Marken
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Product benchmarking
7.3.12.4. Strategic initiatives
7.3.13. Myonex
7.3.13.1. Company overview
7.3.13.2. Financial performance
7.3.13.3. Product benchmarking
7.3.13.4. Strategic initiatives
7.3.14. Yourway
7.3.14.1. Company overview
7.3.14.2. Financial performance
7.3.14.3. Product benchmarking
7.3.14.4. Strategic initiatives
List of Tables
Table 1 List of abbreviations
Table 2 North America clinical trial equipment & ancillary solutions market, by region, 2018 - 2030 (USD Million)
Table 3 North America clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
Table 4 North America clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
Table 5 U.S. clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
Table 6 U.S. clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
Table 7 Canada clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
Table 8 Canada clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
Table 9 Europe clinical trial equipment & ancillary solutions market, by region, 2018 - 2030 (USD Million)
Table 10 Europe clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
Table 11 Europe clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
Table 12 Germany clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
Table 13 Germany clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
Table 14 UK clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
Table 15 UK clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
Table 16 France clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
Table 17 France clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
Table 18 Italy clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
Table 19 Italy clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
Table 20 Spain clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
Table 21 Spain clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
Table 22 Denmark clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
Table 23 Denmark clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
Table 24 Sweden clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
Table 25 Sweden clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
Table 26 Norway clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
Table 27 Norway clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
Table 28 Asia Pacific clinical trial equipment & ancillary solutions market, by region, 2018 - 2030 (USD Million)
Table 29 Asia Pacific clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
Table 30 Asia Pacific clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
Table 31 China clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
Table 32 China clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
Table 33 Japan clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
Table 34 Japan clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
Table 35 India clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
Table 36 India clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
Table 37 South Korea clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
Table 38 South Korea clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
Table 39 Australia clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
Table 40 Australia clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
Table 41 Thailand clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
Table 42 Thailand clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
Table 43 Latin America clinical trial equipment & ancillary solutions market, by region, 2018 - 2030 (USD Million)
Table 44 Latin America clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
Table 45 Latin America clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
Table 46 Brazil clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
Table 47 Brazil clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
Table 48 Mexico clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
Table 49 Mexico clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
Table 50 Argentina clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
Table 51 Argentina clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
Table 52 Colombia clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
Table 53 Colombia clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
Table 54 MEA clinical trial equipment & ancillary solutions market, by region, 2018 - 2030 (USD Million)
Table 55 MEA clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
Table 56 MEA clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
Table 57 South Africa clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
Table 58 South Africa clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
Table 59 Saudi Arabia clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
Table 60 Saudi Arabia clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
Table 61 UAE clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
Table 62 UAE clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
Table 63 Kuwait clinical trial equipment & ancillary solutions market, by product, 2018 - 2030 (USD Million)
Table 64 Kuwait clinical trial equipment & ancillary solutions market, by phase, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Clinical trial equipment & ancillary solutions market: Market outlook
Fig. 14 Clinical trial equipment & ancillary solutions market: Competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Clinical trial equipment & ancillary solutions market driver impact
Fig. 20 Clinical trial equipment & ancillary solutions market restraint impact
Fig. 21 Clinical trial equipment & ancillary solutions market strategic initiatives analysis
Fig. 22 Clinical trial equipment & ancillary solutions market: Product movement analysis
Fig. 23 Clinical trial equipment & ancillary solutions market: Product outlook and key takeaways
Fig. 24 Sourcing market estimates and forecast, 2018 - 2030
Fig. 25 Procurement market estimates and forecast, 2018 - 2030
Fig. 26 Equipment market estimates and forecast, 2018 - 2030
Fig. 27 Ancillaries market estimates and forecast, 2018 - 2030
Fig. 28 Rental market estimates and forecast, 2018 - 2030
Fig. 29 Equipment market estimates and forecast, 2018 - 2030
Fig. 30 Ancillaries market estimates and forecast, 2018 - 2030
Fig. 31 Supply/Logistics market estimates and forecast, 2018 - 2030
Fig. 32 Transportation market estimates and forecast, 2018 - 2030
Fig. 33 Packaging market estimates and forecast, 2018 - 2030
Fig. 34 Others market estimates and forecast, 2018 - 2030
Fig. 35 Service market estimates and forecast, 2018 - 2030
Fig. 36 Calibrations market estimates and forecast, 2018 - 2030
Fig. 37 Equipment servicing market estimates and forecast, 2018 - 2030
Fig. 38 Others market estimates and forecast, 2018 - 2030
Fig. 39 Other products market estimates and forecast, 2018 - 2030
Fig. 40 Clinical trial equipment & ancillary solutions market: phase movement analysis
Fig. 41 Clinical trial equipment & ancillary solutions market: phase outlook and key takeaways
Fig. 42 Phase I market estimates and forecasts, 2018 - 2030
Fig. 43 Phase II market estimates and forecasts, 2018 - 2030
Fig. 44 Phase III market estimates and forecasts, 2018 - 2030
Fig. 45 Phase IV market estimates and forecasts, 2018 - 2030
Fig. 46 Global clinical trial equipment & ancillary solutions market: Regional movement analysis
Fig. 47 Global clinical trial equipment & ancillary solutions market: Regional outlook and key takeaways
Fig. 48 Global clinical trial equipment & ancillary solutions market share and leading players
Fig. 49 North America market share and leading players
Fig. 50 Europe market share and leading players
Fig. 51 Asia Pacific market share and leading players
Fig. 52 Latin America market share and leading players
Fig. 53 Middle East & Africa market share and leading players
Fig. 54 North America, by country
Fig. 55 North America
Fig. 56 North America market estimates and forecasts, 2018 - 2030
Fig. 57 U.S.
Fig. 58 U.S. market estimates and forecasts, 2018 - 2030
Fig. 59 Canada
Fig. 60 Canada market estimates and forecasts, 2018 - 2030
Fig. 61 Europe
Fig. 62 Europe market estimates and forecasts, 2018 - 2030
Fig. 63 UK
Fig. 64 UK market estimates and forecasts, 2018 - 2030
Fig. 65 Germany
Fig. 66 Germany market estimates and forecasts, 2018 - 2030
Fig. 67 France
Fig. 68 France market estimates and forecasts, 2018 - 2030
Fig. 69 Italy
Fig. 70 Italy market estimates and forecasts, 2018 - 2030
Fig. 71 Spain
Fig. 72 Spain market estimates and forecasts, 2018 - 2030
Fig. 73 Denmark
Fig. 74 Denmark market estimates and forecasts, 2018 - 2030
Fig. 75 Sweden
Fig. 76 Sweden market estimates and forecasts, 2018 - 2030
Fig. 77 Norway
Fig. 78 Norway market estimates and forecasts, 2018 - 2030
Fig. 79 Asia Pacific
Fig. 80 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 81 China
Fig. 82 China market estimates and forecasts, 2018 - 2030
Fig. 83 Japan
Fig. 84 Japan market estimates and forecasts, 2018 - 2030
Fig. 85 India
Fig. 86 India market estimates and forecasts, 2018 - 2030
Fig. 87 Thailand
Fig. 88 Thailand market estimates and forecasts, 2018 - 2030
Fig. 89 South Korea
Fig. 90 South Korea market estimates and forecasts, 2018 - 2030
Fig. 91 Australia
Fig. 92 Australia market estimates and forecasts, 2018 - 2030
Fig. 93 Latin America
Fig. 94 Latin America market estimates and forecasts, 2018 - 2030
Fig. 95 Brazil
Fig. 96 Brazil market estimates and forecasts, 2018 - 2030
Fig. 97 Mexico
Fig. 98 Mexico market estimates and forecasts, 2018 - 2030
Fig. 99 Argentina
Fig. 100 Argentina market estimates and forecasts, 2018 - 2030
Fig. 101 Colombia
Fig. 102 Colombia market estimates and forecasts, 2018 - 2030
Fig. 103 Middle East and Africa
Fig. 104 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 105 South Africa
Fig. 106 South Africa market estimates and forecasts, 2018 - 2030
Fig. 107 Saudi Arabia
Fig. 108 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 109 UAE
Fig. 110 UAE market estimates and forecasts, 2018 - 2030
Fig. 111 Kuwait
Fig. 112 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 113 Market share of key market players - Clinical trial equipment & ancillary solutions market

Companies Mentioned

  • Ancillare, LP
  • Imperial CRS, Inc.
  • Woodley Equipment Company Ltd.
  • Thermo Fisher Scientific, Inc.
  • Parexel International (MA) Corporation
  • Emsere (MediCapital Rent)
  • Quipment SAS
  • IRM
  • Marken
  • Myonex
  • Yourway

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages131
PublishedFebruary 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 2.96 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.1 Billion
Compound Annual Growth Rate8.1%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

AI-based Clinical Trials Solution Provider Market Size, Share and Trends Analysis Report by Therapeutic Application, Clinical Trial Phase, End-use, and Region 2024-2030 - Product Image

AI-based Clinical Trials Solution Provider Market Size, Share and Trends Analysis Report by Therapeutic Application, Clinical Trial Phase, End-use, and Region 2024-2030

  • Report
  • 118 Pages
  • Global
From
Clinical Trial Biorepository & Archiving Solutions Market Size, Share & Trends Analysis Report By Service (Biorepository Services, Archiving Solution Services), By Product, By Phase, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Clinical Trial Biorepository & Archiving Solutions Market Size, Share & Trends Analysis Report By Service (Biorepository Services, Archiving Solution Services), By Product, By Phase, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 192 Pages
  • Global
From
Clinical Trial Equipment & Ancillary Solutions Market by Product, Type, Phase, End-Use, Indication - Global Forecast 2025-2030 - Product Image

Clinical Trial Equipment & Ancillary Solutions Market by Product, Type, Phase, End-Use, Indication - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Virtual Clinical Trials Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2024 to 2032 - Product Image

Virtual Clinical Trials Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2024 to 2032

  • Report
  • 170 Pages
  • Global
From
Clinical Trial Equipment & Ancillary Solutions Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Clinical Trial Equipment & Ancillary Solutions Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.